Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-05-13 @ 5:18 PM
Study NCT ID:
NCT01640405
Status:
COMPLETED
Last Update Posted:
2019-04-11
First Post:
2012-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TTD-12-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |